Search research articles
Contact Us
Filters
Showing results (21-30 of 43) with videos related to
Page
of 5
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 28, 2021
Cancer Cell-Specific Major Histocompatibility Complex II Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment
Amber M Johnson, Jennifer M Boland, Julia Wrobel, et al.
Bioconjugate Chemistry
|
May 27, 2022
Evaluating the Effect of Dye-Dye Interactions of Xanthene-Based Fluorophores in the Fluorosequencing of Peptides
James L Bachman, Christopher D Wight, Angela M Bardo, et al.
Journal of the American Medical Informatics Association : JAMIA
|
April 24, 2016
Automated identification of molecular effects of drugs (AIMED)
Safa Fathiamini, Amber M Johnson, Jia Zeng, et al.
Molecular Cancer Research : MCR
|
May 16, 2019
Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1
Trisha R Sippel, Amber M Johnson, Howard Y Li, et al.
Journal of Medicinal Chemistry
|
June 17, 2026
Synthetic Approaches to the New Drugs Approved During 2024
Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Database : the Journal of Biological Databases and Curation
|
April 11, 2015
Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature
Guocai Chen, Jieyi Zhao, Trevor Cohen, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
Journal of Medicinal Chemistry
|
February 3, 2025
Synthetic Approaches to the New Drugs Approved during 2023
Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 18, 2020
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma
Amber M Johnson, Bonnie L Bullock, Alexander J Neuwelt, et al.
Cold Spring Harbor Molecular Case Studies
|
January 5, 2017
ALK: a tyrosine kinase target for cancer therapy
Vijaykumar R Holla, Yasir Y Elamin, Ann Marie Bailey, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 43) with videos related to
Sort By:
Page
of 5
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 28, 2021
Cancer Cell-Specific Major Histocompatibility Complex II Expression as a Determinant of the Immune Infiltrate Organization and Function in the NSCLC Tumor Microenvironment
Amber M Johnson, Jennifer M Boland, Julia Wrobel, et al.
Bioconjugate Chemistry
|
May 27, 2022
Evaluating the Effect of Dye-Dye Interactions of Xanthene-Based Fluorophores in the Fluorosequencing of Peptides
James L Bachman, Christopher D Wight, Angela M Bardo, et al.
Journal of the American Medical Informatics Association : JAMIA
|
April 24, 2016
Automated identification of molecular effects of drugs (AIMED)
Safa Fathiamini, Amber M Johnson, Jia Zeng, et al.
Molecular Cancer Research : MCR
|
May 16, 2019
Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1
Trisha R Sippel, Amber M Johnson, Howard Y Li, et al.
Journal of Medicinal Chemistry
|
June 17, 2026
Synthetic Approaches to the New Drugs Approved During 2024
Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Database : the Journal of Biological Databases and Curation
|
April 11, 2015
Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature
Guocai Chen, Jieyi Zhao, Trevor Cohen, et al.
Molecular Cancer
|
March 27, 2024
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study
Blessie Elizabeth Nelson, Jason Roszik, Jibran Ahmed, et al.
Journal of Medicinal Chemistry
|
February 3, 2025
Synthetic Approaches to the New Drugs Approved during 2023
Scott P France, Erick A Lindsey, Emma L McInturff, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 18, 2020
Cancer Cell-Intrinsic Expression of MHC Class II Regulates the Immune Microenvironment and Response to Anti-PD-1 Therapy in Lung Adenocarcinoma
Amber M Johnson, Bonnie L Bullock, Alexander J Neuwelt, et al.
Cold Spring Harbor Molecular Case Studies
|
January 5, 2017
ALK: a tyrosine kinase target for cancer therapy
Vijaykumar R Holla, Yasir Y Elamin, Ann Marie Bailey, et al.
Page
of 5